Similarly to COVID-19, in other ARVIs, the levels of IFNγ-inducible CXCL10 in BAL and plasma correlate with the severity of the disease (Hayney et al., 2017; Almansa et al., 2011; Buszko et al., 2020). The gene discussed is IFNG; the disease is COVID-19.